F.D.A.’s Approval of Drug for Autism Upends Review Process


By Christina Jewett from NYT Health https://ift.tt/6zGq2UP
Intellectual Disabilities, Regulation and Deregulation of Industry, Disabilities, Autism, United States Politics and Government, Generic Brands and Products, Labeling and Labels (Product), Folic Acid, Doctors
Previous Post Next Post

Contact Form